Table 2.

Combination medication

Treatment	Telitacicept group (n = 11)	Control group (n = 22)	P value
RASi, n (%)	7 (63.64)	16 (72.73)	0.696
SGLT2i, n (%)	6 (54.55)	9 (40.91)	0.458
Corticosteroids, n (%)	2 (18.18)	7 (31.82)	0.681
immunosuppressants, n (%)	1 (4.55)	3 (27.27)	0.097
Corticosteroids plus immunosuppressants, n (%)	1 (9.09)	13 (59.09)	0.009*

The categorical variables were presented as n (%). RASi, renin-angiotensin system inhibitors; SGLT2i, sodium-glucose co-transporter-2 inhibitors; MMF, mycophenolate mofetil. ^*P < 0.05